Dicamba Tolerant Canola - MON 94100
In 2019, Health Canada received a submission to allow the sale of a genetically modified (GM) canola variety referred to as dicamba tolerant canola – MON 94100. This canola variety has been genetically modified to exhibit tolerance to the herbicide dicamba (3,6-dichloro-2-methoxybenzoic acid).
In order to determine whether this GM canola variety could be sold in Canada as food, the scientists at Health Canada conducted a scientific assessment that ensured this variety is safe for consumption. Our scientists also needed to assess how this GM canola variety was developed and whether the event can be toxic or cause allergic reactions.
Scientists with expertise in molecular biology, microbiology, toxicology, chemistry, and nutrition conducted a thorough analysis of the data and the protocols provided by the applicant to ensure the validity of the results.
Following this assessment, it was determined that the changes made to this GM canola variety do not pose a greater risk to human health than canola varieties currently available on the Canadian market. In addition, Health Canada also concluded that this GM canola variety would have no impact on allergies, and that there are no differences in the nutritional value of this GM canola variety compared to other traditional canola varieties available for consumption.
Health Canada’s assessment of MON 94100 was conducted according to the Guidelines for the Safety Assessment of Novel Foods. The approach taken by Health Canada in the safety assessment of GM foods is based upon scientific principles developed through expert international consultation over the last 20 years with agencies such as the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), and the Organization for Economic Co-operation and Development (OECD). The approach taken by Canada is currently applied by regulatory agencies around the world in countries such as the European Union, Australia/New Zealand, Japan, and the United States.